[Research progress of secondary metabolites produced by microorganisms--enzyme inhibitors (author's transl)].
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors; D000190:Actinomyces / Q000378:metabolism; D000617:Aminoglycosides; D000818:Animals; D000900:Anti-Bacterial Agents / Q000096:biosynthesis; D000903:Antibiotics, Antineoplastic / Q000096:biosynthesis; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors; D004791:Enzyme Inhibitors / Q000302:isolation & purification / Q000378:metabolism* / Q000494:pharmacology; D006640:Histidine Decarboxylase / Q000037:antagonists & inhibitors; D007976:Leupeptins / Q000096:biosynthesis / Q000494:pharmacology; D008780:Methyltransferases / Q000037:antagonists & inhibitors; D010957:Plasmids; D011480:Protease Inhibitors; D011549:Pseudomonas / Q000032:analysis; D051381:Rats; D012459:Salicylates / Q000494:pharmacology
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D004791:Enzyme Inhibitors; D007976:Leupeptins; D011480:Protease Inhibitors; D012459:Salicylates; D004299:Dopamine beta-Hydroxylase; D008780:Methyltransferases; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D006640:Histidine Decarboxylase